Revolution Medicines (RVMD) Shares Outstanding (Weighted Average) (2018 - 2026)

Revolution Medicines' Shares Outstanding (Weighted Average) history runs 9 years deep, the most recent figure standing at $198.1 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 5.29% year-over-year to $198.1 million; the TTM figure through Mar 2026 stood at $198.1 million (up 5.29% YoY), while the FY2025 annual figure was $190.1 million, up 13.35% from the prior year.
• Shares Outstanding (Weighted Average) was $198.1 million for Q1 2026 at Revolution Medicines, up from $190.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $198.1 million in Q1 2026 to a low of $74.2 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $137.8 million across 5 years, with a median of $164.7 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) advanced 1.2% in 2022, then surged 73.71% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $80.6 million in 2022, then surged by 40.34% to $113.1 million in 2023, then soared by 48.24% to $167.7 million in 2024, then gained by 13.35% to $190.1 million in 2025, then rose by 4.19% to $198.1 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $198.1 million (Q1 2026), $190.1 million (Q4 2025), and $188.7 million (Q3 2025), per Business Quant data.